InfuSystem Holdings, Inc. (INFU)
Market Cap | 114.92M |
Revenue (ttm) | 134.86M |
Net Income (ttm) | 2.35M |
Shares Out | 21.01M |
EPS (ttm) | 0.11 |
PE Ratio | 49.73 |
Forward PE | 27.35 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 64,500 |
Open | 6.06 |
Previous Close | 6.06 |
Day's Range | 5.44 - 6.06 |
52-Week Range | 5.29 - 9.97 |
Beta | 1.76 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Mar 4, 2025 |
About INFU
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambu... [Read more]
Financial Performance
In 2024, InfuSystem Holdings's revenue was $134.86 million, an increase of 7.22% compared to the previous year's $125.79 million. Earnings were $2.35 million, an increase of 168.92%.
Financial StatementsNews

InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU) Q4 2024 Results Conference Call March 4, 2025 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele -...

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024.

InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025.

InfuSystem Set For Strong Year
InfuSystem Holdings achieved 11% YoY revenue growth and expanded EBITDA margins by 2.8 percentage points in 3Q24. INFU's business plan focuses on high ROI revenue and less capital-intensive growth thr...

InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024.

InfuSystem Appoints Ronald Hundzinski to the Board of Directors
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Appoints Ronald Hundzinski to the Board of Directors.

InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU) Q3 2024 Results Conference Call November 7, 2024 9:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steel...

InfuSystem Reports Third Quarter 2024 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Third Quarter 2024 Financial Results.

InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024.

InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024.

InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care ...

InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lake Street's 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024.

InfuSystem Set For Strong Second Half
InfuSystem's stock could soar in late 2024 and throughout 2025 after consolidating in the sub-$7.00/share range. INFU's underlying business is stronger than ever, with new partnerships and revenue str...

InfuSystem Holdings, Inc. (INFU) Q2 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU) Q2 2024 Earnings Call Transcript August 8, 2024 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich Dilorio - Chief Executive Officer Barry Stee...

InfuSystem Reports Second Quarter 2024 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Second Quarter 2024 Financial Results.

InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems.

InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024.

InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024.

InfuSystem Announces $20 Million Stock Repurchase Program
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces $20 Million Stock Repurchase Program.

InfuSystem Holdings, Inc. (INFU) Q1 2024 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU) Q1 2024 Results Conference Call May 9, 2024 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich Dilorio - Chief Executive Officer Barry Steele -...

InfuSystem Reports First Quarter 2024 Financial Results
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports First Quarter 2024 Financial Results.

InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024.

InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K.

InfuSystem Holdings, Inc. (INFU) Q4 2023 Earnings Call Transcript
InfuSystem Holdings, Inc. (NYSE:INFU) Q4 2023 Earnings Conference Call March 14, 2022 9:00 AM ET

InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023.